Freezes and reductions in National Institutes of Health funding are reverberating beyond universities and research labs to startups in the biotech industry.
A U.S. district judge foiled the Food and Drug Administration's plan put forth under the Biden administration to regulate lab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback